International Flavors & Fragrances Inc banner

International Flavors & Fragrances Inc
F:IFF

Watchlist Manager
International Flavors & Fragrances Inc Logo
International Flavors & Fragrances Inc
F:IFF
Watchlist
Price: 66.68 EUR -3.03% Market Closed
Market Cap: €17.1B

International Flavors & Fragrances Inc
Investor Relations

International Flavors & Fragrances makes the scent and taste ingredients that go inside other companies’ products. It sells flavor systems for foods and drinks, fragrance compounds for perfumes, personal care, and household products, and specialty ingredients used in health, wellness, and industrial applications. Its customers are mainly consumer packaged goods companies, food and beverage makers, personal care brands, and manufacturers that need a specific ingredient profile or sensory effect. IFF makes money by selling these ingredients and by designing custom formulas for customers. In many cases, it works closely with a customer to match a taste, smell, texture, or performance target, then supplies that formula over time as part of the customer’s production chain. This means the business is less about selling to end consumers and more about being a behind-the-scenes supplier that helps big brands create finished products. What makes IFF different is that its products are often built into a customer’s recipe or manufacturing process, which can make them hard to replace. The company’s role sits in the middle of the value chain: it combines chemistry, application know-how, and manufacturing to turn raw materials into specialized ingredients that other companies use in their own branded goods.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2026
Call Date
May 6, 2026
AI Summary
Q1 2026

Strong start: IFF said first-quarter results came in better than expected, with revenue of greater than $2.7 billion and 3% sales growth driven by volume growth across all businesses.

Margins up: Adjusted operating EBITDA rose to $568 million, up 8%, and margin expanded 110 basis points to 20.7%, the highest since Q2 2022.

Guidance reaffirmed: Management kept full-year 2026 guidance unchanged despite a tougher macro backdrop and conflict-related pressure in the Middle East.

Inflation pressure: The company expects rising energy, logistics, and later raw material costs to weigh on Q2 before pricing actions catch up in the second half.

Portfolio reshaping: The Food Ingredients sale process is progressing well, while the soy crush, concentrates and lecithin business was sold in March for $110 million.

Scent weakness: Fine Fragrance and fragrance ingredients, especially commodity ingredients, were a drag, and management expects Q2 EBITDA to be lower than Q1 largely because of this and Middle East disruption.

Key Financials
Revenue
greater than $2.7 billion
Sales growth
3%
Adjusted operating EBITDA
$568 million
Adjusted operating EBITDA margin
20.7%
Taste sales
$656 million
Taste adjusted operating EBITDA
$153 million
Food Ingredients sales
$839 million
Food Ingredients adjusted operating EBITDA
$114 million
Health & Biosciences sales
$595 million
Health & Biosciences adjusted operating EBITDA
$153 million
Scent sales
$651 million
Scent adjusted operating EBITDA
$148 million
Cash flow from operations
$257 million
Free cash flow
$92 million
Capital expenditures
$165 million
Cash and cash equivalents
$562 million
Gross debt
$5.85 billion
Net debt to credit adjusted EBITDA
2.5x
Soy crush, concentrates and lecithin divestiture
$110 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Glenn Robert Richter
Executive VP and Chief Financial & Business Transformation Officer
No Bio Available
Dr. Jennifer Amy Johnson Ph.D.
Executive VP, General Counsel & Corporate Secretary
No Bio Available
Mr. Simon Herriott
President of Health & Biosciences
No Bio Available
Mr. Yuvraj Arora
Executive VP & President of Nourish
No Bio Available
Mr. Jon Erik Fyrwald
CEO & Director
No Bio Available
Mr. Ralf Finzel Ph.D.
Executive VP & Global Operations Officer
No Bio Available
Ms. Beril Yildiz
Senior VP, Corporate Controller & Chief Accounting Officer
No Bio Available
Mr. Michael DeVeau
Senior Vice President of Corporate Finance & Investor Relations
No Bio Available
Mr. Vic Verma
Executive VP & Chief Information Officer
No Bio Available
Ms. Deborah Borg
Executive VP and Chief Human Resources, Communications and Diversity, Equity & Inclusion Officer
No Bio Available

Contacts

Address
NEW YORK
New York City
521 W 57th St
Contacts
+12127655500.0
www.iff.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett